Filing Details
- Accession Number:
- 0001209191-23-044004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-01 16:41:54
- Reporting Period:
- 2023-07-28
- Accepted Time:
- 2023-08-01 16:41:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358762 | Reata Pharmaceuticals Inc | RETA | Pharmaceutical Preparations (2834) | 113651945 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1685986 | Shamim Ruff | 5320 Legacy Drive Plano TX 75024 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2023-07-28 | 1,250 | $92.20 | 8,609 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2023-07-28 | 6,666 | $92.20 | 15,275 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2023-07-28 | 319 | $92.20 | 15,594 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2023-07-28 | 8,235 | $164.53 | 7,359 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2023-07-28 | 1,250 | $0.00 | 1,250 | $92.20 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2023-07-28 | 6,666 | $0.00 | 6,666 | $92.20 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2023-07-28 | 319 | $0.00 | 319 | $92.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2031-04-15 | No | 4 | M | Direct | |
| 3,334 | 2031-04-15 | No | 4 | M | Direct | |
| 0 | 2031-04-15 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $164.25 to $164.69. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The options vested on July 15, 2021.
- The options vest in three equal yearly installments through April 15, 2024, subject to continued service through each vesting date.
- The options vested on July 15, 2021.
Billionaire Hedge Funds
